obesity drug news today glp-1 october 27 2025 Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Lilly's new GLP-1 pill is

Handy, and R

PMID: 23334697 LaRusch J, Jung J, General I.J, Lewis M.D, Park H.W, Brand R.E, Gelrud A, Anderson M.A, Banks P.A, Conwell D, Lawrence C, Romagnuolo J, Baillie J, Alkaade S, Cote G, Gardner T.B, Amann S.T, Slivka A, Sandhu B, Aloe A, Kienholz M.L, Yadav D, Barmada M.M, Bahar I, Lee M.G, Whitcomb D.C, and the North American Pancreatology Study Group

Iran J Basic Med Sci 18:240246

While encouraging, this studys retrospective design, lack of placebo control, small sample size, and subjective outcome reporting limit its interpretability

For example, altered levels of short-chain ACs, including C2 and C3, have been observed in coronary artery disease and diabetes [6, 55]